Evotec (OTCMKTS:EVTCY) Reaches New 52-Week Low – What’s Next?

Evotec SE (OTCMKTS:EVTCY) hit a new 52-week low on Tuesday . The company traded as low as $4.52 and last traded at $4.58, with a volume of 777233 shares traded. The stock had previously closed at $4.40.

Evotec Stock Up 4.1 %

The company has a market cap of $1.51 billion, a price-to-earnings ratio of 10.73 and a beta of 0.98. The company has a current ratio of 2.57, a quick ratio of 2.50 and a debt-to-equity ratio of 0.53. The firm’s fifty day moving average price is $3.84 and its 200-day moving average price is $4.42.

Evotec Company Profile

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.